Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p8 | Arthritis and other joint diseases: translational and clinical | ECTS2016

A clinical study to examine thresholds of joint space width and joint space area for identification of knee osteoarthritis

Ljuhar Richard , Norman Benjamin , Ljuhar Davul , Haftner Tobias , Hladuvka Jiri , Mai Mary Bui Thi , Canhao Helena , Rodrigues Ana Maria , Gouveia Nelia , Branco Jaime , Nehrer Stefan , Fahrleitner-Pammer Astrid , Dimai Hans-Peter

Objective: Osteoarthritis (OA) is a degenerative, slowly developing joint disease. Although clinical indications of OA can vary among different definitions there is a general agreement that the disease is associated with cartilage narrowing. However, there is no general consensus about the threshold below which the joint space width (JSW)/joint space area (JSA) can be certain indicators for the state of OA. Therefore this study evaluates these limits to reveal quantitative inf...

ba0003pp237 | Osteoporosis: evaluation and imaging | ECTS2014

Reference intervals for bone turnover markers in Spanish premenopausal women

Guanabens Nuria , Filella Xavier , Monegal Ana , Gomez-Vaquero Carmen , Bonet Maria , Buquet Dolors , Casado Enrique , Cerda Dacia , Erra Alba , Martinez Silvia , Montala Nuria , Pitarch Concepcion , Kanterewickz Eduardo , Sala Miquel , Suris Xavier , Torres Ferran , de Reumatoloia Lab Oscat Study Group Societat Catalana

Background and aims: Bone turnover markers (BTMs) are used in clinical practice for assessing patients with osteoporosis and their treatment. In Spain it is necessary to fine-tune the reference intervals, since they were established years ago in a low number of individuals. The aims of this study were to establish robust reference intervals for BTMs in healthy young premenopausal Spanish women and to investigate the factors influencing BTMs.Methods: 185 ...

ba0007p122 | (1) | ICCBH2019

Congenital hyperinsulinism of infancy in a child with autosomal dominant hypocalcaemia type 1 due to an activating calcium sensing receptor mutation

Sastre Ana , Shah Pratik , Gevers Evelien

Background: Autosomal dominant hypocalcaemia (ADH) is caused by activating mutations of the calcium sensing receptor (CaSR). Symptomatology ranges from asymptomatic hypocalcaemia to paraesthesia, tetani, laryngospasm and seizures. This is the first report of congenital hyperinsulinism (CHI) in a child with ADH.Presenting problem and clinical management: A female infant, born at term from non-consanguineous parents. She presented on D2 with persistent asy...

ba0001pp132 | Cancer and bone: basic, translational and clinical | ECTS2013

The central role of the histone demethylase JHDM1D in the regulation of tumor associated genes in bone tumor-related cells

Thaler Roman , Spitzer Silvia , Haider Florian , Karlic Heidrun , Klaushofer Klaus , Varga Franz

Tumor development occurs often by over-activation of members of the RAS-oncogene family (small GTPases (sGTPs)). By blocking the mevalonate pathway, aminobisphosphonates (BPs), and statines prevent activation of GTPs by inhibiting their post-translational prenylation. As we have shown, this induces apoptosis in U2OS osteosarcoma cells by re-activation of FAS expression via epigenetic DNA demethylation (1).The histone demethylase JHD...

ba0001pp422 | Osteoporosis: treatment | ECTS2013

Bisphosphonates poisonous action

Maria Buyko , Victoria Atrushkevich

Introduction: Bisphosphonates gain increasingly greater significance in treatment oncologic diseases with bone metastasis. However, a lot of articles have lately been published in dental and oncological journals on jaw osteonecrosis (ONJ) associated with long-term ingestion of bisphosphonates. Besides extension of clinical recommendations for zolendronate use, most commonly referred to in connection with ONJ, for treatment of Paget’s diseaseand other disturbances of bone ...

ba0002p179 | (1) | ICCBH2013

The impact of selective serotonin reuptake inhibitors on bone mineral density in the pediatric and young adult population

Feuer Alexis , Vogiatzi Maria

Objective: Serotonin is a neurotransmitter with multiple functions in the gastrointestinal tract and CNS. Recent animal studies indicate that serotonin regulates bone mass and remodelling. In humans, a handful of studies have shown decreased bone mineral density (BMD) in adults treated with selective serotonin reuptake inhibitors (SSRI) for depressive symptoms. Although SSRI’s are prescribed in pediatric practice, there are few studies examining the effect of SSRIs on bon...

ba0003pp384 | Other diseases of bone and mineral metabolism | ECTS2014

Wnt16 as a new regulator of vascular calcification

Nurminskaya Maria , Beazley Kelly

Objective: Vascular calcification contributes to the pathogenesis of atherosclerosis, hypercholesterolemia, end stage renal disease, and diabetes, and is caused by genetic ablation of matrix Gla protein (MGP) in mice. Genetic ablation of MGP in mice results in excessive calcification of the vessel wall associated with a chondrocyte-like trans-differentiation in smooth muscle cells (VSMCs). Canonical β-catenin signaling is activated in the calcified arterial Mgp&#8722...

ba0002p103 | (1) | ICCBH2013

Celiac disease and bone disorders: diagnosis age influence

Brunetto Oscar , Cau Ana Arias , Insua Claudia , Marzet Chriatian Boggio

Celiac disease (CD) is a frequent cause of malabsortion in childhood and affects calcium and vitamin D absorption.Aim: Analyze the vitamin D levels and bone mineral density (BMD) at diagnosis in patients affected with CD, and the influence of the age of diagnosis in the clinical presentation.Patient: 52 patients (female: 26) were evaluated.Results: The percentage with vitamin D deficiency (<20 ng/ml) was ...

ba0003pp259 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

High sclerostin levels in primary biliray cirrhosis: relationship with cholestasis and bone remodelling

Ruiz-Gaspa Silvia , Gifre Laia , Pares Albert , Miquel Rosa , Peris Pilar , Monegal Ana , Dubreuil Marta , Arias Ana , Guanabens Nuria

Background and aims: Low bone formation is the main pathogenic mechanism of osteoporosis in primary biliary cirrhosis (PBC). Sclerostin, an inhibitor of the Wnt pathway, is involved in the regulation of osteoblastogenesis and little is known about its role in the development of bone disease in PBC. Thus, we evaluated the circulating levels of sclerostin and its relationship to bone mass, the parameters of mineral metabolism and liver disease severity.Met...

ba0007p215 | (1) | ICCBH2019

Evaluating the natural history of subcutaneous fat necrosis

Lautatzis Maria-Elena , Harrington Jennifer

Background: Subcutaneous fat necrosis (SCFN) of the newborn is an uncommon condition most commonly seen in term infants who have experienced perinatal stress presenting as nodules or plaques on the face, back or upper extremities. The associated complication of hypercalcemia is thought to be secondary to elevated 1,25-OH vitamin D from increased expression of 1-alpha hydroxylase from inflammatory granulomatous cells. However the natural history of SCFN, associated hypercalcemi...